Key Findings on GLP-1 Use in MS
GLP-1 receptor agonists (e.g., Ozempic, Wegovy) show potential in multiple sclerosis (MS) as potential neuroprotective, anti-inflammatory, and weight-loss agents. Preclinical studies…
Categories
Latest Blog Posts
- Image showing CT Brain Anatomy
- MS explained – Using the Pool Model, by Aaron Boster, MD
- How to Prevent Falls When You Have MS
- What’s the Connection Between MS and Seizures?
- Can Vitamin D Help Manage MS?
- Dysphagia – What causes it and how treated?
- Coping with Sudden MS Sweating When It’s Cold
- Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis:
- Comprehensive Guide to Bladder Dysfunction in MS
- The Surprising Side Effect She Didn’t Dare Talk About
- Incidentalomas in Multiple Sclerosis
- How to Treat MS Pain
- Wheelchair Fit for Function and Support
- Scientists Find New Evidence Linking Epstein-Barr Virus to MS
- MS Study Alert: How Can We Prevent Falls in People Who Use Wheelchairs? Researchers Recruiting for Two Studies
- New Study Points to Racial and Ethnic Differences in MS-Related Deaths
- For Your Loved Ones
- Heat Sensitivity With Multiple Sclerosis
- Driving rehabilitation program
- Top 5 Ways to Relieve OsteoArthritis Pain
